Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran etexilate vs Warfarin in Japanese patients with non-valvular atrial fibrillation
NCT01136408Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dabigatran etexilate oral solution in Atrial fibrillation (AFib), sponsored by Boehringer Ingelheim. Started Nov 2005; status: completed.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01136408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136408.